Added 24 days ago Drug news

FDA accepts Avycaz sNDA to include the treatment of complicated urinary tract infections and complicated intra-abdominal infections in pediatric patients . Allergan.

Allergan plc announced that the FDA has accepted for review the company's supplemental New Drug Application (sNDA) for AvyCaz(ceftazidime and...

Added 1 month ago Drug news

FDA gives 510(k) clearance for BD Phoenix CPO detect test to identify carbapenemase-producing organisms- Becton Dickinson

Becton, Dickinson and Company announced the FDA has given 510(k) clearance of the BD Phoenix CPO detect test, which will...

Added 1 month ago Drug news

Theravance Biopharma sells Vibativ to Cumberland Pharma.

Theravance Biopharma, Inc. announced the sale of its proprietary antibiotic, Vibativ (telavancin), to Cumberland Pharmaceuticals, Inc. a specialty pharmaceutical company...

Guidelines on Urological Infections

The European Association of Urology (EAU) Urological Infections Guidelines Panel has compiled these clinical guidelines to provide medical professionals with evidence-based information and recommendations for...

Added 2 years ago

The Prevention of Early-onset Neonatal Group B Streptococcal Disease

The purpose of this guideline is to provide guidance for obstetricians, midwives and neonatologists on the prevention of early-onset (less than 7 days of age) neonatal group B streptococcal (EOGBS) disease...

Added 6 years ago

Fever in under 5s: assessment and initial management

This guideline covers the assessment and early management of fever with no obvious cause in children aged under 5.

Added 5 years ago

Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.

The CFTR potentiator, ivacaftor (IVA), has been widely used in the treatment of cystic fibrosis (CF) patients with the G551D mutation. To date, there has been limited information on the microbiological status...

Added 10 months ago

Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Goal-directed therapy has been used for severe sepsis and septic shock in the intensive care unit.

Added 1 year ago

Early, goal-directed therapy for septic shock – a patient-level meta-analysis.

After a single-center trial and observational studies suggesting that early, goal-directed therapy (EGDT) reduced mortality from septicshock, three multicenter trials (ProCESS, ARISE, and ProMISe) showed no benefit.

Added 1 year ago